Psoriatic Disease and Tuberculosis Nowadays
Psoriasis is a chronic, relapsing and remitting inflammatory skin and joint disease that has a prevalence of 2-3% in the world’s population, whereas of 1–2% in Europe. The traditional concept of psoriasis as the “healthy people’s” disease has been recently revised because of ever-increasing reports...
Main Authors: | Nicola Balato, Luisa Di Costanzo, Fabio Ayala, Anna Balato, Alessandro Sanduzzi, Marialuisa Bocchino |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/747204 |
Similar Items
-
Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients.
by: Bernardetta Maresca, et al.
Published: (2012-01-01) -
A Long-Term Follow-Up of Angiolymphoid Hyperplasia with Eosinophilia Treated by Corticosteroids: When a Traditional Therapy is Still Up-to-Date
by: Serena Lembo, et al.
Published: (2011-03-01) -
Zoon’s Balanitis: Benign or Premalignant Lesion?
by: Nicola Balato, et al.
Published: (2009-05-01) -
Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
by: Alessandro Sanduzzi, et al.
Published: (2020-03-01) -
Anti-Inflammatory Properties of Low and High Doxycycline Doses: An In Vitro Study
by: Roberta Di Caprio, et al.
Published: (2015-01-01)